MedPath

Definition of ARDS in Qinghai Province: Verification of Berlin Definition Plateau Criteria

Conditions
ARDS
High Altitude
Registration Number
NCT04199650
Lead Sponsor
Southeast University, China
Brief Summary

The severity stratification criteria for acute respiratory distress syndrome (ARDS) in Xi'ning Qinghai province (mean altitude: 2200m) were clarified according to the oxygenation index (PaO2/FiO2).

Detailed Description

This study is a single-center retrospective study. According to the Berlin diagnostic standard, ARDS patients admitted to the Department of severe Medicine, affiliated Hospital of Qinghai University from January 2018 to December 2018 were divided into three groups: mild (153mmHg \< PaO2/ FiO2 ≥ 230 mmHg), moderate (76mmHg \< PaO2/ FiO2 ≥ 153 mmHg) and severe (PaO2/ FiO2 ≥ 76 mmHg). The ICU mortality, 28-day mortality, non-ventilator time in ICU, ICU hospitalization time and non-I hospitalization were observed respectively. The difference of CU time and total hospitalization days.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
253
Inclusion Criteria
  • 18 years of age
  • Meet the diagnostic criteria of ARDS
  • Receive invasive mechanical ventilation
Exclusion Criteria
  • Receive a large number of hormone shock therapy in a short period of time
  • Death within a short period of time (< 24 h) after mechanical ventilation
  • No chest imaging data
  • Data missing

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
28-days mortality rate28 days after discharge

Mortality at 28 days of hospitalization

ICU mortalityup to 24 weeks

Mortality during treatment in ICU

Secondary Outcome Measures
NameTimeMethod
Hospital length of stayup to 24 weeks

Total length of stay in hospital

Ventilator Free timeup to 24 weeks

Ventilator time not used in ICU

Ventilator timeup to 24 weeks

Ventilator time in ICU

Trial Locations

Locations (1)

ChunPan

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath